Alterity Therapeutics (ATHE) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Alterity Therapeutics (ATHE) is Neutral.

The composite score behind that read is -0.18, weighing +0.09 of bullish evidence against -0.37 bearish.

Alterity Therapeutics last closed at $3.12, +1.63% on the session.

Against the IVW growth benchmark the position is +0.83% over the forecast window.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

20 graded predictions for ATHE so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

Alterity Therapeutics is classified under Health Care / Biotechnology, with a market capitalisation of $58.62M.

StockMap tracks Alterity Therapeutics as the 305th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Alterity Therapeutics ranks 294th of 381 in the group, against a group median of -0.08.